{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT05048901","recordId":"NCT05048901","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05048901-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct05048901.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct05048901.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2021-09-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2021-09-09","publishedAt":"2026-08-23","recordId":"NCT05048901","recordSha256":"bfff73ecf0f849ca0662ee49e0acbd25e89bba7f0eca661651eafc601275cfc3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05048901?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2023-04-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2023-04-05","publishedAt":"2026-08-23","recordId":"NCT05048901","recordSha256":"f580ed1c1c50345b14270910d9ca05c1f735c191008989c156a06914560c4ce4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05048901?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2024-07-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2024-07-02","publishedAt":"2026-08-23","recordId":"NCT05048901","recordSha256":"de4cec0ba70c7c15089b1252b9b799611d16116ea06f358a2eeade35e47e7786","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05048901?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2026-04-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2026-04-06","publishedAt":"2026-08-23","recordId":"NCT05048901","recordSha256":"4986a1623b42b8a4e9fe5b117391c4b2fe0abea042cba309c4a868e506e66c35","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05048901?a=4&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"0441e97e99479ea57c44d9d3d3e7662d7541014eeeb1b8119dd8dbbbaa9f6b88"}}